Cosmos Health (COSM) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$73.7M

Revenue (quarter)

$19.0M

Revenue growth (year over year)

+28.76%

Gross profit (trailing twelve months)

$7.6M

Gross margin

10.27%

Net income (trailing twelve months)

−$24.4M

Net income (quarter)

−$6.1M

Net income growth (year over year)

−115.22%

Net margin

−33.08%

Return on equity

−104.00%

EPS (trailing twelve months)

−$0.67

Book value per share

$0.26

P/E (trailing twelve months)

—

Price to book

1.86

Debt to assets

66.36%

Payout ratio

—

Dividend yield

—

Company profile

Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.

• Is Cosmos Health (COSM) profitable?

  No. Cosmos Health reported a net loss of $24.4M over the trailing twelve months.

• How much revenue does Cosmos Health (COSM) make?

  Cosmos Health generated $73.7M in revenue over the trailing twelve months, up 28.76% year over year.

• How do I buy stock in Cosmos Health (COSM)?

  COSM trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.